首页 | 本学科首页   官方微博 | 高级检索  
     

特发性肺纤维化急性加重的研究进展
引用本文:梅益枝,刘超. 特发性肺纤维化急性加重的研究进展[J]. 海南医学, 2017, 28(7). DOI: 10.3969/j.issn.1003-6350.2017.07.035
作者姓名:梅益枝  刘超
作者单位:蚌埠医学院第一附属医院呼吸内科,安徽 蚌埠,233000
摘    要:特发性肺纤维化(IPF)患者病程中出现的突然的临床恶化称为特发性肺纤维化急性加重(AE-IPF).IPF患者急性加重病情进展快、发病率逐年增高,其预后差,是IPF患者病死的主要原因.目前AE-IPF的病因及发病机制不明,临床诊断困难,且目前无特效的治疗方法,是临床医生面临的诊治难点之一.

关 键 词:特发性肺纤维化  急性加重  发病机制  治疗

Research progress on acute exacerbation of idiopathic pulmonary fibrosis
MEI Yi-zhi,LIU Chao. Research progress on acute exacerbation of idiopathic pulmonary fibrosis[J]. Hainan Medical Journal, 2017, 28(7). DOI: 10.3969/j.issn.1003-6350.2017.07.035
Authors:MEI Yi-zhi  LIU Chao
Abstract:Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) is a sudden clinical deterioration in the disease course of IPF, whose incidence is increasing year by year. AE-IPF has rapid progression and poor prognosis, and becomes the main cause of death in patients with IPF. So far, the etiology and pathogenesis of AE-IPF is unclear. Difficulties in diagnosis and lack of effective treatments for AE-IPF are the problems faced by doctors.
Keywords:Idiopathic pulmonary fibrosis (IPF)  Acute exacerbation  Pathogenesis  Treatment
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号